EverSource Wealth Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$186K Buy
5,126
+91
+2% +$3.11K 0.01% 1039
2026
Q1
$167K Buy
5,035
+861
+21% +$36.5K 0.01% 1156
2025
Q4
$193K Buy
4,174
+611
+17% +$25.6K 0.01% 961
2025
Q3
$125K Buy
3,563
+1,079
+43% +$37.5K ﹤0.01% 1161
2025
Q2
$73.5K Buy
2,484
+2,190
+745% +$62.5K ﹤0.01% 1373
2025
Q1
$8.78K Sell
294
-20
-6% -$611 ﹤0.01% 2177
2024
Q4
$9K Buy
314
+37
+13% +$1.22K ﹤0.01% 2053
2024
Q3
$10.7K Hold
277
﹤0.01% 1823
2024
Q2
$10.7K Sell
277
-41
-13% -$1.42K ﹤0.01% 1817
2024
Q1
$11.7K Sell
318
-358
-53% -$12.5K ﹤0.01% 1602
2023
Q4
$20.8K Buy
676
+383
+131% +$9.59K ﹤0.01% 1211
2023
Q3
$6.55K Hold
293
﹤0.01% 1584
2023
Q2
$6.3K Hold
293
﹤0.01% 1633
2023
Q1
$7.03K Buy
293
+126
+75% +$3.34K ﹤0.01% 1518
2022
Q4
$3.87K Hold
167
﹤0.01% 1701
2022
Q3
$3K Buy
+167
New +$2.94K ﹤0.01% 1519
2022
Q1
Sell
-190
Closed -$4K 1727
2021
Q4
$4K Buy
+190
New +$3.7K ﹤0.01% 1315

Other funds holding COLL

EverSource Wealth Advisors's COLL Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Collegium Pharmaceutical (COLL) stake by 1.8% in Q2 2026, buying an estimated $3.11K and bringing the position to 5,126 shares worth $186K. The position accounts for 0.01% of the portfolio, ranked #1039.

EverSource Wealth Advisors first reported a position in COLL in Q4 2021 and has held it in 17 quarters since. The position peaked at $193K in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • EverSource Wealth Advisors held 5,126 shares of Collegium Pharmaceutical worth $186K as of Q2 2026.
  • EverSource Wealth Advisors bought 91 Collegium Pharmaceutical shares in Q2 2026, an estimated $3.11K.
  • Collegium Pharmaceutical made up 0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1039 holding.
  • EverSource Wealth Advisors first reported a position in Collegium Pharmaceutical in Q4 2021 and has held it in 17 quarters since.
  • EverSource Wealth Advisors's Collegium Pharmaceutical position peaked at $193K in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.